Per Aniansson

Per Aniansson has extensive work experience in various roles and industries. Per is currently serving as an Investment Director at Karolinska Development. In 2022, they took on leadership roles as Chairman of the Board at Colorifix Limited, Turnpike Group, and Henlez. Additionally, they serve as a Board Member at PharmNovo and AnaCardio. In 2014, they became a Member of the Board of Directors at AAC Clyde Space. Per has also worked as an Advisor at the 3W Foundation and as a General Partner at RSQ Capital. Furthermore, they had a role as a Board Member at Star Syringe Ltd. since 2006.

Per Aniansson's education history is as follows:

In 1982, they attended Sigrid Rudebecks Gymnasium in Gothenburg and obtained a Baccalaureate degree in Natural Sciences in 1986. During the same period, in 1984-1985, they also studied at Lycée International de St Germain en Laye in France, focusing on Naturvetenskap (Natural Sciences).

From 1986 to 1987, Per Aniansson attended The Armed Forces Interpreter Academy (TolkS), where they obtained an Officer degree with a specialization in Russian.

In 1987, they enrolled in Chalmers University of Technology and completed a Master's Degree in Engineering Physics in 1992. During their studies, from 1991 to 1992, they also spent a year at EPFL (École polytechnique fédérale de Lausanne) specializing in Engineering Physics.

In 1989-1990, Per Aniansson studied at Stockholm School of Economics, although the specific degree and field of study are not provided.

Lastly, in 1997, they attended INSEAD where they obtained an MBA degree, focusing on Finance and Entrepreneurship.